JP2016518446 免疫刺激性オリゴヌクレオチドを含む新規のワクチン組成物

Settings

Stemming

Single Family Member

Include NPL

Feedback

Goto Application

Office

Japan

Application Number 2016514012

Application Date 12.05.2014

Publication Number 2016518446

Publication Date 23.06.2016

Grant Number 6505084

Grant Date 05.04.2019

Publication Kind B2

IPC

View more classifications

View less classifications

CPC

View more classifications

View less classifications

Applicants ゾエティス・サービシーズ・エルエルシー

Inventors ドミノウスキー，ポール・ジョゼフ
ライ，シャラス・ケイ
スライ，ローレル・メアリー
クック，コーリー・パトリック
ムワンギ，ダンカン
フォス，デニス・エル
クレブス，リチャード・リー

Agents 小野　新次郎
小林　泰
竹内　茂雄
山本　修
泉谷　玲子

Priority Data 61/823,189 14.05.2013 US

Title

(JA) 免疫刺激性オリゴヌクレオチドを含む新規のワクチン組成物

Abstract

(JA)

本発明は、抗原成分及びアジュバント成分を含むワクチン組成物であって、該アジュバント成分は、Ｐクラス免疫刺激性オリゴヌクレオチド、ならびに、サポニン及びステロールの組み合わせ、または油、及び任意に、１つ以上の乳化剤を含む油相、のいずれかを含み、該油相がワクチン組成物の２〜２０ｖ／ｖ％を構成し、該抗原成分が、ＥＨＶ抗原またはリーシュマニア抗原である、ワクチン組成物を提供する。

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39	Medicinal preparations containing antigens or antibodies
12	Viral antigens
245	Herpetoviridae, e.g. herpes simplex virus
27	Equine rhinopneumonitis virus

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47	Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
06	Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47	Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
06	Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
26	Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47	Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
06	Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
28	Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47	Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
30	Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
34	Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Processing

National Phase Entries

Authority File

Settings

Feedback

Goto Application

1. JP2016518446 - 免疫刺激性オリゴヌクレオチドを含む新規のワクチン組成物

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
P	SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31	Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12	Antivirals
20	for DNA viruses
22	for herpes viruses

C	CHEMISTRY; METALLURGY
12	BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
N	MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
2710	dsDNA Viruses
00011	dsDNA Viruses
16011	Herpesviridae
16034	Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Y	SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
02	TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
A	TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
50	in human health protection, e.g. against extreme weather
30	Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change